Company: EVLVW
Filing Date: 2025-08-14
Form Type: 10-Q
Source: 0001805385-25-000009
Chunk: 177

Company: Evolv Technologies Holdings, Inc.
Filing Date: 2025-08-14
Form: 10-Q
Item: Part I, Item 1
Chunk 177
---
 and six months ended June 30, 2024, respectively. There was no related party revenue for the three and six months ended June 30, 2025.

The accompanying notes are an integral part of these condensed consolidated financial statements.

F-3

EVOLV TECHNOLOGIES HOLDINGS, INC.

CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY

(In thousands, except share amounts)

(Unaudited)

Common StockAdditionalPaid-inCapitalAccumulated Other Comprehensive Income (Loss)AccumulatedDeficitTotalStockholders’EquitySharesAmountBalances at December 31, 2024159,602,069 $16 $472,331 $(32)$(354,664)$117,651 Issuance of common stock upon net exercise of stock options281,709 — 20 — — 20 Issuance of common stock upon vesting of restricted stock units3,389,364 — — — — — Stock-based compensation cost— — 5,125 — — 5,125 Cumulative translation adjustment— — — (46)— (46)Net loss— — — — (1,689)(1,689)Balances at March 31, 2025163,273,142 $16 $477,476 $(78)$(356,353)$121,061 Issuance of common stock upon net exercise of stock options5,628,670 1 6,427 — — 6,428 Issuance of common stock upon vesting of restricted stock units1,724,550 — — — — — Stock-based compensation cost— — 5,781 — — 5,781 Cumulative translation adjustment— — — (85)— (85)Net loss— — — — (40,535)(40,535)Balances at June 30, 2025170,626,362 $17 $489,684 $(163)$(396,888)$92,650 Balances at December 31, 2023151,310,080 $15 $444,825 $(53)$(300,647)$144,140 Issuance of common stock upon net exercise of stock options519,089 1 301